🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Breast cancer is the most common malignant tumor in women. Recurrent or met...
Status
Recruiting
Location
Shusen Wang
Start Date
2018-07-25
Trial ID
NCT03561740
Treatments Being Tested
This Phase III multicenter trial investigates treatment intensification for...
Status
Active Not Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2025-10-04
Trial ID
NCT07248670
Treatments Being Tested
The investigators aim to investigate whether incorporating on-treatment EBV...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-06-01
Trial ID
NCT04072107
Treatments Being Tested
The latest guidelines recommend Gemcitabine plus Capecitabine as the first ...
Status
Unknown
Location
Department of Oncology, Ruijin Hospital
Start Date
2020-01-05
Trial ID
NCT03959150
Treatments Being Tested
This study aims to evaluate a personalized approach for treating patients w...
Status
Recruiting
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2026-05-01
Trial ID
NCT07590024
Treatments Being Tested
Breast cancer (BC) is one of most prevalent malignant tumors in the world. ...
Status
Recruiting
Location
Henan cancer hospital
Start Date
2021-09-28
Trial ID
NCT05063136
Treatments Being Tested
This is a prospective platform study that will investigate the outcomes of ...
Status
Recruiting
Location
National Cancer Centre Singapore
Start Date
2022-11-17
Trial ID
NCT05517135
The main questions it aims to answer are: 1. Does the combination of GP in...
Status
Active Not Recruiting
Location
Fujian Cancer Hospital
Start Date
2025-02-17
Trial ID
NCT06712888
Treatments Being Tested
The survival rate of patients with pathological complete response (pCR) aft...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2019-01-01
Trial ID
NCT06700382
Treatments Being Tested
RATIONALE: Vaccines made from gene-modified tumor cells may help the body b...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2008-07-02
Trial ID
NCT00727441
Treatments Being Tested